Family History & Glaucoma Screening

Family History & Glaucoma Screening– My Parent or Sibling Has Glaucoma. Do I Need to Get Tested Too? Short answer, YES. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history, says Dr Shibal Bhartiya.

Your parent or sibling has just been diagnosed with glaucoma. Or perhaps they have had it for years and you are only now realising what that means for you.

You are asking the right question. Most people do not ask it until it is too late. Dr Shibal Bhartiya explains more.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Family History Changes Everything in Glaucoma

Glaucoma is not random. It runs in families. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history.

That is not a small increase. That is a fundamental shift in your risk category.

And yet most first degree relatives of glaucoma patients never get tested. They wait for symptoms. Glaucoma does not produce symptoms until significant, often irreversible damage has already occurred. By the time your vision changes, the window for early intervention has often narrowed considerably.

This is why family history glaucoma screening exists: not to frighten you, but to find the disease before it finds you.


What Is the First Degree Relative Glaucoma Risk?

A first degree relative is a parent, sibling, or child: someone who shares approximately 50 percent of your genetic material.

The first degree relative glaucoma risk is well established in research. Studies consistently show that having one affected first degree relative raises your risk of developing primary open angle glaucoma to approximately 1 in 5. Having two affected first degree relatives raises it further.

The risk is highest when the affected relative developed glaucoma before the age of 60, when the disease was severe at diagnosis, or when the relative required surgery rather than drops alone.

First degree relative glaucoma risk is also higher in specific ethnic groups. People of African descent carry a higher baseline risk. In India, primary angle closure glaucoma has a higher prevalence than in Western populations, and this pattern also clusters in families.

Knowing your family history is not just useful. In glaucoma, it is clinically essential.


Does Having a Family History Mean You Will Definitely Get Glaucoma?

No. A family history raises your risk. It does not guarantee disease.

Many people with a strong family history never develop glaucoma. Many develop it only in their seventies or eighties, when treatment is straightforward and vision loss is entirely preventable with monitoring.

What family history means clinically is this: you belong in a higher-risk group that benefits from earlier, more frequent screening for glaucoma. That is all. It is not a sentence. It is a schedule.


Glaucoma Risk Factors Beyond Family History

Family history is the single strongest glaucoma risk factor after age. But it does not act alone. Several other glaucoma risk factors combine with family history to raise your personal risk further.

Age is the most consistent glaucoma risk factor across all populations. Risk rises steeply after 40 and continues to increase with each decade.

Raised eye pressure, also called ocular hypertension, is a major modifiable glaucoma risk factor. Not everyone with high eye pressure develops glaucoma, but the risk is substantially elevated, particularly when combined with family history.

Myopia (near-sightedness) increases glaucoma risk, particularly for primary open angle glaucoma. Moderate to high myopia is an independent glaucoma risk factor.

Thin corneas reduce the accuracy of eye pressure measurements and are independently associated with glaucoma progression risk.

Systemic conditions including diabetes, hypertension, and migraine are associated with higher glaucoma risk in some studies, particularly for normal tension glaucoma.

Previous eye injury or steroid use — whether eye drops, inhalers, skin creams, or oral steroids — can raise eye pressure and trigger steroid-induced glaucoma, particularly in genetically susceptible individuals.

When you combine a family history of glaucoma with one or more of these additional glaucoma risk factors, the case for early screening becomes compelling.


What Does Screening for Glaucoma in Adults Actually Involve?

Screening for glaucoma in adults is not a single test. It is a short, structured examination that covers the four main parameters of glaucoma assessment.

Eye pressure measurement — intraocular pressure is measured using a non-contact tonometer or applanation tonometry. This takes less than a minute. It is painless.

Optic nerve assessment — the ophthalmologist examines the optic disc through a dilated pupil or with specialist lenses. The size, shape, and symmetry of the optic nerve head are evaluated. This is the most important part of any glaucoma screening examination.

Corneal thickness measurement — pachymetry measures corneal thickness, which affects the interpretation of eye pressure readings.

OCT imaging — optical coherence tomography of the RNFL and optic nerve head provides structural data that can detect early glaucoma damage before any symptoms or visual field changes occur. You can read more about what an OCT scan shows and how to interpret your report.

Visual field testing — in higher-risk individuals, a visual field test maps peripheral and central vision to detect any functional loss.

Gonioscopy — in patients where angle closure is suspected, gonioscopy examines the drainage angle of the eye. This is particularly relevant in Indians, where angle closure glaucoma is more prevalent.

A complete screening for glaucoma in adults takes approximately 45 to 60 minutes at a specialist glaucoma clinic, including dilation time.


When Should Screening for Glaucoma Early Begin?

The timing of screening for glaucoma early depends on your personal risk profile.

For most adults with a first degree relative with glaucoma and no other risk factors, screening should begin at 40. Some guidelines recommend starting at 35 in high-risk ethnic groups or when the affected relative had early-onset disease.

For adults with a family history plus additional glaucoma risk factors: high myopia, raised eye pressure found incidentally, or very thin corneas, earlier screening is warranted. In these cases, a baseline examination in the mid-thirties is reasonable.

For adults with no family history and no other risk factors, screening for glaucoma in adults is generally recommended from the age of 40 as part of a routine comprehensive eye examination.

The question is not whether to screen. The question is when to start and how often to repeat.


How Often Should You Be Screened?

Frequency depends on what the first examination shows.

If the first screening is entirely normal: normal eye pressure, healthy optic nerve, normal OCT, annual or biennial review is appropriate for most people in the family history risk group.

If the first screening shows borderline findings: slightly elevated pressure, a suspicious optic disc, or mildly thin RNFL on OCT, more frequent monitoring is needed. Your glaucoma specialist will advise a specific schedule based on your individual findings.

If the first screening confirms early glaucoma, you move from a screening pathway to a treatment and monitoring pathway. Early glaucoma detected through family history glaucoma screening is almost always manageable, and vision loss is highly preventable with timely intervention.


Detecting Glaucoma Early: Why It Matters So Much

Glaucoma destroys retinal nerve fibres. Once those fibres are gone, they do not regenerate. The vision lost to glaucoma does not return.

Detecting glaucoma early changes the entire trajectory of the disease. A patient diagnosed at the very beginning of structural damage, before any visual field loss, has an excellent long-term prognosis with appropriate treatment. A patient diagnosed after significant optic nerve damage faces a harder, narrower path.

The difference between these two patients is often not biology. It is timing. It is whether someone in the family said: you should get checked, and whether the person listened.

Detecting glaucoma early through structured family history screening is one of the highest-value interventions in all of preventive ophthalmology. It costs very little. It changes lives.


What Happens If Glaucoma Is Found?

Finding glaucoma early through family history glaucoma screening is not bad news. It is good news delivered at the right time.

Early glaucoma in a screened patient is almost always managed with eye drops alone. Treatment is started, eye pressure is brought to a safe target, and the optic nerve is monitored regularly. Most patients with early glaucoma, managed well and consistently, never develop significant visual impairment.

The goal of glaucoma treatment is not to cure the disease. It is to slow it so completely that it never affects your quality of life. That goal is realistic. It is achieved every day for patients who are found early.

What changes if glaucoma is found is not your life. It is your schedule, a few extra clinic visits and a bottle of eye drops. That is the trade. For preserved vision over decades, it is a very good trade.


What If the Screening Is Normal?

A normal screening result is genuinely reassuring, but it is not a permanent all-clear.

Glaucoma can develop or progress at any age. A normal result at 40 means you do not have glaucoma now. It does not mean you will never develop it. This is why regular, repeated family history glaucoma screening matters more than a single normal result.

Think of it the way you think of blood pressure checks or dental appointments. A normal result today schedules your next check. It does not cancel all future checks.


Where to Get Screened in Gurgaon

If you have a family history of glaucoma and have not yet been assessed, a structured glaucoma risk evaluation with a glaucoma specialist in Gurgaon is the right next step.

A specialist assessment goes beyond a basic eye pressure check. It includes optic nerve imaging, corneal thickness measurement, OCT analysis, and visual field testing, and if indicated, gonioscopy. This gives you a complete, documented baseline against which future examinations can be compared.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram. She offers structured glaucoma risk assessments for patients with a family history of glaucoma, including those seeking a second opinion on existing results or diagnoses.

Appointments: +91 88826 38735

Upload your reports for a structured review.


Gentle Takeaway

Your parent’s diagnosis is information. It is not fate.

The single most useful thing you can do with that information is act on it earlybefore symptoms, before damage, before the window narrows.

Glaucoma caught early is a very manageable disease. Glaucoma caught late is a much harder conversation. The difference is often a single timely appointment.

Book one.

Family History as a Glaucoma Risk Trigger, Not a Footnote

A positive family history remains one of the most clinically actionable risk signals in glaucoma, yet also one of the most under-leveraged.

First-degree relatives of patients with glaucoma have a substantially higher lifetime risk (often 3–4× or more), and importantly, may develop disease earlier and with more aggressive trajectories.

Dr Bhartiya’s editorial along with geneticists from AIIMS, New Delhi and Marengo Asia, emphasises on integrating genomics into practice (PMID: 41523176), reinforcing that family history is not merely a background detail but a proxy for inherited susceptibility that should actively trigger structured screening pathways.

In practical terms, this shifts glaucoma care from opportunistic detection to targeted risk-based screening, where identifying and counselling family members becomes a core extension of clinical responsibility, not an optional add-on.

Clinical Reality (Family History & Glaucoma Screening in India)

  • Family history is one of the strongest risk factors — but often ignored
    Many patients only realise its importance after damage has already occurred.
  • Screening is not routine for relatives
    Unlike diabetes or hypertension, glaucoma screening is rarely proactively advised to family members.
  • “No symptoms” delays first check
    High-risk individuals often wait for visual complaints, by which time disease may already be advanced.
  • Normal eye check-ups may miss early glaucoma
    Routine vision tests without optic nerve evaluation or fields can miss disease.
  • Younger family members are often overlooked
    Screening is delayed until later decades, despite risk beginning earlier.
  • One normal test gives false reassurance
    A single normal OCT or pressure reading does not rule out future risk.

What Good Screening Looks Like (If You Have a Family History of Glaucoma)

  • Early baseline screening — before symptoms
    Ideally by age 30–40, or earlier if multiple affected relatives.
  • Comprehensive evaluation, not just vision or pressure
    Includes optic nerve assessment, OCT, visual fields, corneal thickness.
  • Risk-stratified follow-up
    Frequency depends on baseline findings — not “come if needed.”
  • Family-based screening approach
    First-degree relatives (parents, siblings, children) are actively advised evaluation.
  • Longitudinal monitoring
    Tracking change over time is key — not single reports.
  • Clear patient education
    Understanding risk improves adherence to follow-up and screening.

Family History & Glaucoma Screening: What’s Missed vs What Matters

SituationWhat Patients Often AssumeClinical Reality (India Context)What Good Care Looks Like
Family history present“It’s not affecting me yet”Risk is significantly higher even without symptomsEarly baseline screening for all first-degree relatives
No symptoms“I’ll get checked if I notice a problem”Glaucoma remains silent until irreversible damageScreening before symptoms begin
Routine eye check-up“My eyes were checked, so I’m fine”Standard vision tests may miss early glaucomaComprehensive glaucoma evaluation (OCT + fields + nerve exam)
Age factor“I’m too young to worry”Risk can begin earlier in those with family historyScreening from 30–40 years or earlier if high risk
Single normal report“Everything was normal last time”One test cannot rule out future progressionPeriodic follow-up based on risk profile
Family awareness“No one told my family to get tested”Screening advice is often not extended to relativesProactive, family-based screening approach
Follow-up“I’ll come back if needed”Irregular follow-up delays detection of early changesStructured, risk-based follow-up intervals
Understanding risk“It’s just genetic, nothing to do now”Early detection can prevent vision lossEducation + long-term monitoring strategy
Disease perception“Glaucoma means high pressure only”Many patients develop glaucoma at normal pressuresBroader risk assessment beyond IOP
Goal of screening“Just to rule it out”Screening is about early detection and tracking changeLong-term risk management, not one-time clearance

Frequently Asked Questions: Family History and Glaucoma Screening

Does glaucoma run in families?

Yes. Having a first degree relative: a parent, sibling, or child with glaucoma raises your lifetime risk of developing the disease by four to nine times. Family history is the single strongest glaucoma risk factor after age. Structured family history glaucoma screening is recommended for all first degree relatives of glaucoma patients.

What is the risk of glaucoma if a parent has it?

The first degree relative glaucoma risk is approximately 1 in 5 for primary open angle glaucoma, significantly higher than the general population risk of around 1 in 50. The risk is higher when the affected parent developed glaucoma early, had severe disease, or required surgery.

At what age should I get screened for glaucoma if a parent has it?

Screening for glaucoma early should begin at 40 for most adults with a first degree relative with glaucoma. Those with additional glaucoma risk factors, high myopia, raised eye pressure, or thin corneas, should consider a baseline examination from the mid-thirties.

What does glaucoma screening involve?

Screening for glaucoma in adults includes eye pressure measurement, optic nerve assessment through a dilated pupil, corneal thickness measurement, OCT imaging of the nerve fibre layer, and visual field testing in higher-risk individuals. A complete specialist assessment takes approximately 45 to 60 minutes.

Can glaucoma skip a generation?

Yes. The genetic inheritance pattern of glaucoma is complex and not fully understood. Glaucoma can skip generations or manifest differently across family members. A negative family history in your parents does not fully exclude risk if grandparents or siblings are affected.

What glaucoma risk factors increase my risk beyond family history?

Key glaucoma risk factors that combine with family history include age over 40, raised eye pressure, moderate to high myopia, thin corneas, diabetes, and previous steroid use. The more risk factors present alongside family history, the stronger the case for early and frequent screening.

If my glaucoma screening is normal, do I still need follow-up?

Yes. A normal result at first screening does not mean permanent all-clear. Glaucoma can develop at any point. Annual or biennial review is recommended for adults with a family history of glaucoma, even when the initial assessment is entirely normal.

Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Steroid Induced Glaucoma

Steroids carry a risk that many patients, and even some prescribing doctors, overlook. They can silently raise the pressure inside your eye. And raised eye pressure, left unchecked, damages the optic nerve and causes glaucoma, says Dr Shibal Bhartiya. Timely monitoring, not waiting for symptoms, is what prevents irreversible optic nerve damage.

Steroids are powerful medicines. Doctors use them to treat inflammation, autoimmune disease, allergies, and dozens of other conditions. But they can trigger a silent rise in eye pressure, often without early symptoms.

This condition is called steroid-induced glaucoma. It is one of the most preventable causes of serious vision loss in India.


Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


What Are Steroids and Why Do Doctors Use Them?

Steroids, specifically corticosteroids, reduce inflammation in the body. Doctors prescribe them in many forms: eye drops, oral tablets, inhalers, nasal sprays, skin creams, and injections directly into or around the eye.

Common brand names include prednisolone, dexamethasone, betamethasone, triamcinolone, and budesonide. Many are available over the counter in India without a prescription. This is a serious problem.

People often self-medicate with steroid eye drops for redness or allergy, sometimes for months, without any eye pressure monitoring.


How Do Steroids Raise Eye Pressure?

Your eye constantly produces a fluid called aqueous humour. This fluid drains out through a mesh-like structure called the trabecular meshwork. Steroids interfere with this drainage. The fluid builds up. Pressure inside the eye rises.

This process is called a steroid response. It does not happen to everyone. But certain people are far more susceptible. Glaucoma patients, first-degree relatives of glaucoma patients, people with high myopia, and diabetics have a higher risk of becoming steroid responders.

In a steroid responder, eye pressure can rise significantly, sometimes within days of starting treatment. More often, the rise is gradual and goes unnoticed for weeks or months.

The danger is that raised eye pressure causes no pain. No redness. No blurring. You feel nothing until the optic nerve is already damaged.


Which Steroids Carry the Highest Risk?

Eye drops carry the greatest risk. They deliver steroids directly into the eye in concentrated form. Potent drops like prednisolone and dexamethasone raise eye pressure more than weaker formulations like fluorometholone or loteprednol. Duration matters too: the longer the use, the greater the risk.

Periocular injections, injections around the eye used in uveitis and retinal disease, release steroids slowly over weeks to months. Triamcinolone acetonide injections are a particularly common cause of prolonged eye pressure elevation. Once the depot is in place, it cannot be removed easily.

Oral steroids carry a lower but real risk, especially with prolonged use at high doses.

Inhaled steroids for asthma and COPD, and nasal sprays for allergic rhinitis, carry a small but measurable risk, particularly with long-term use.

Skin creams applied around the eyes can absorb through the eyelid skin and raise eye pressure. This is underappreciated and often missed.


Symptoms of Steroid-Induced Glaucoma

In most cases, there are no symptoms. This is what makes steroid-induced glaucoma dangerous.

By the time vision changes become noticeable, significant optic nerve damage has often already occurred. Peripheral vision goes first — and most people do not notice peripheral vision loss until it is severe.

In rare cases, when eye pressure rises very rapidly, patients may experience headache, eye ache, blurring, or haloes around lights. But this is the exception, not the rule.

The only way to detect steroid-induced glaucoma early is to check eye pressure regularly while on any steroid therapy, especially eye drops.


How Is Steroid-Induced Glaucoma Diagnosed?

Diagnosis requires a full glaucoma evaluation. This includes:

Tonometry measures eye pressure. Normal pressure is usually between 10 and 21 mmHg. Steroid responders may reach 30, 40, or even higher.

Gonioscopy examines the drainage angle to confirm the trabecular meshwork is open, as it is in steroid glaucoma, distinguishing it from angle-closure glaucoma.

OCT (Optical Coherence Tomography) scans the optic nerve and the nerve fibre layer to detect structural damage before vision loss is symptomatic.

Visual field testing maps the field of vision to detect functional loss.

Optic disc examination allows direct visualisation of the nerve head for signs of damage and cupping.

Steroid-induced glaucoma looks identical to primary open-angle glaucoma on examination. The distinguishing clue is the history: elevated pressure that developed after starting a steroid, and that improves when the steroid is stopped or changed.


Is Steroid-Induced Glaucoma Reversible?

The short answer: sometimes, if caught early enough.

In many patients, stopping or switching the steroid allows eye pressure to normalise within weeks. If the optic nerve has not been damaged, the condition is fully reversible.

But optic nerve damage is permanent. Glaucoma does not recover. If pressure has been high long enough to injure the nerve, even partially, that damage remains even after the steroid is stopped.

This is why early detection is critical. A short course of steroid eye drops that goes unmonitored can cause permanent vision loss that no treatment can reverse.

Caught early, steroid glaucoma is one of the most manageable forms of glaucoma. That is why monitoring matters.


Treatment Options

Step one is always to reconsider the steroid.

Can the dose be reduced? Can the steroid be stopped? Is there a possibility of using a less potent formulation? For eye drops, switching from prednisolone to fluorometholone or loteprednol often reduces the pressure response significantly.

Sometimes the underlying condition, uveitis, for example, requires continued steroid treatment. In these cases, eye pressure must be managed medically.

Pressure-lowering eye drops are the first line of treatment. The same drops used in primary glaucoma: prostaglandin analogues, beta-blockers, carbonic anhydrase inhibitors, and alpha agonists, are effective in steroid glaucoma.

Laser treatment (SLT) can improve drainage through the trabecular meshwork and reduce dependence on drops.

Surgery: trabeculectomy or a glaucoma drainage device , is reserved for cases where drops and laser do not control pressure adequately. Surgery in steroid glaucoma is generally highly effective.

For patients who have received a periocular steroid injection and cannot have it removed, sustained medical treatment is the mainstay until the depot is absorbed.


The Indian Context: A Hidden Epidemic

India has a particular problem with steroid-induced glaucoma. Steroid eye drops are widely available without prescription. Patients self-treat for red eyes, allergy, and post-operative care, often on the advice of pharmacists or non-specialist practitioners.

Many patients arrive in my clinic having used potent steroid drops every day for six, twelve, or even twenty-four months. Their pressure is grossly elevated. The optic nerves are damaged. Their peripheral vision is affected and will not return.

This is preventable. Every patient using steroid eye drops needs their eye pressure monitored. Every patient on long-term systemic steroids deserves at least an annual eye check. This is not optional.

As a fellowship-trained glaucoma specialist seeing patients from across India, Dr Bhartiya offers structured steroid glaucoma risk assessments for patients on long-term steroid therapy, including those referred by other treating doctors.


When Should You See a Glaucoma Specialist?

See a fellowship-trained glaucoma specialist if:

  • You are using steroid eye drops for more than two weeks
  • You have been prescribed a periocular steroid injection
  • You are on long-term oral steroids and have never had your eye pressure checked
  • You have a family history of glaucoma and are on any steroid therapy
  • You are a known glaucoma patient who requires steroids for any reason
  • Your eye pressure has been noted to be high on a routine eye check
  • If you have been told your eye pressure is high while on steroids, an independent glaucoma second opinion can clarify whether treatment or monitoring is needed.

Do not wait for symptoms. There are none, until it is too late. Bring your steroid prescription and any previous eye pressure readings to your appointment.


Clinical Reality (What’s not always obvious)

  • Steroid-induced glaucoma is often silent in the early stages
  • Vision may remain completely normal on routine testing
  • Pressure rise can happen within weeks in some patients, but months in others
  • Not all steroids are equal — eye drops, skin creams, inhalers, and even nasal sprays can contribute
  • The response is individual — some people are “steroid responders” without knowing it
  • Stopping the steroid does not always reverse the damage completely
  • Damage, once established, follows the same irreversible course as primary glaucoma

What Actually Helps (And What Doesn’t)

What helps:

  • Early identification of steroid use (even non-ocular forms)
  • Baseline and follow-up intraocular pressure monitoring
  • Switching to safer alternatives where possible
  • Timely initiation of anti-glaucoma therapy if needed
  • Long-term monitoring even after stopping steroids

What doesn’t help:

  • Assuming “short-term use is always safe”
  • Ignoring non-eye steroid sources (dermatology creams, inhalers)
  • Relying only on vision clarity as a marker of safety
  • Delaying evaluation because symptoms are absent
  • Repeated steroid prescriptions without pressure monitoring

Remember This

Situation / TriggerWhat Patients Often AssumeClinical RealityWhat Should Be Done
Using steroid eye drops“Doctor prescribed it, so it’s safe”Even prescribed steroids can raise eye pressureMonitor IOP within weeks of starting
Using skin creams near eyes“It’s just topical, not affecting eyes”Periocular absorption can increase eye pressureInform ophthalmologist and monitor
Using inhalers for asthma“It doesn’t reach the eye”Chronic use can contribute to pressure risePeriodic eye pressure checks
Short-term steroid use“Too brief to cause harm”Some individuals respond rapidlyEarly follow-up is essential
No symptoms“If I see well, everything is fine”Glaucoma damage is silent initiallyRegular screening, not symptom-based
Stopping steroids“Problem is solved now”Damage may persist or progressContinued monitoring required
Multiple steroid prescriptions“Different doctors, different issues”Cumulative exposure increases riskCentralised tracking of steroid use

Frequently Asked Questions

Can steroid eye drops cause glaucoma even when used for a short time?

A brief course, less than two weeks, rarely causes a clinically significant pressure rise. But risk increases with duration and potency. Any steroid eye drop use lasting more than two weeks warrants a pressure check.

How long does it take for steroids to raise eye pressure?

In highly susceptible individuals, pressure can rise within days. In most steroid responders, the rise occurs over two to six weeks of use. With depot injections, pressure may continue to rise for months.

Does stopping the steroid cure steroid glaucoma?

It normalises the pressure in most patients, yes. But if the optic nerve has already been damaged, that damage is permanent. Stopping the steroid does not restore lost vision.

Can inhaled steroids for asthma cause glaucoma?

Yes, though the risk is lower than with eye drops. Long-term use of high-dose inhaled corticosteroids has been associated with a modest increase in glaucoma risk, particularly in patients who already have elevated eye pressure.

Can steroid skin creams cause glaucoma?

Yes. Creams applied to the face and eyelid skin can absorb into the eye in meaningful amounts. This is an underrecognised cause of steroid-induced ocular hypertension.

What is a steroid responder?

A steroid responder is someone whose eye pressure rises significantly on steroid therapy. Roughly 5% of the general population are high responders. Glaucoma patients, first-degree relatives of glaucoma patients, high myopes, and diabetics have a much higher rate of response.

Is steroid glaucoma the same as regular glaucoma?

The optic nerve damage is identical. The mechanism of pressure elevation differs: steroids impair drainage through the trabecular meshwork. The treatment approach is similar, but the critical first step is always to reassess and if possible stop or reduce the causative steroid.

Can I still use steroids if I have glaucoma?

Yes, but only under close specialist supervision with frequent pressure monitoring. Never use steroid eye drops without the oversight of an ophthalmologist if you have a diagnosis of glaucoma or a family history of the condition.

I had a steroid injection around my eye six months ago and my pressure is still high. What should I do?

This is a recognised complication of periocular depot steroids. The injection releases slowly over months. Pressure management with drops or laser is usually required until the depot is absorbed. See a glaucoma specialist, this situation requires careful, ongoing monitoring.

What should I do if my pharmacist gives me steroid eye drops for a red eye?

Do not use steroid eye drops without a diagnosis from an ophthalmologist. Red eyes have many causes, viral conjunctivitis, allergic conjunctivitis, dry eye, most of which do not always require steroids and some of which can be worsened by them. Always get a proper diagnosis before using any steroid eye drop.


Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic, you can opt for a teleconsult.

More Glaucoma Eye Drops is Not Better Glaucoma Care

More glaucoma eye drops do not guarantee better control. Treatment must be individualised based on riskprogression, and tolerance. Overmedication can increase side effects, reduce adherence, and still fail to protect long-term vision, explains Dr Shibal Bhartiya. Adding more glaucoma medications does not always mean better care and may reflect disease progression requiring proper reassessment.

When glaucoma worsens, many patients assume the next step is simple: add more eye drops.
But glaucoma care is not about the number of medicines. It is about protecting the optic nerve safely over a lifetime.

Sometimes adding drops helps. Sometimes it harms. Good care depends on judgement, sequencing, and long-term strategy.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Glaucoma Is a Long-Arc Disease

Glaucoma damage is slow, silent, and irreversible.

Treatment must balance:

The goal is not perfect numbers. The goal is lifelong, stable vision.


What Is Target Eye Pressure?

Every patient has a target intraocular pressure (IOP), a level considered safe for their optic nerve.

This depends on:

Two patients with the same pressure may need very different treatment. Glaucoma care is about staying below your safe pressure consistently, not just lowering it once.

Dr Bhartiya, along with her colleagues in Australia and Switzerland, has published peer-reviewed research on current perspectives on Target IOP in glaucoma practice, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. Her 2014 paper, Target Intraocular Pressure: Approaches and Options, examines how glaucoma specialists should set, communicate, and revise pressure targets, balancing clinical evidence, patient preferences, and long-term vision outcomes. It is cited by glaucoma surgeons internationally and is freely available on PubMed.


When More Eye Drops Are Not Better

Adding multiple medications can lead to:

  • Redness, burning, and irritation
  • Allergy and eyelid swelling
  • Severe dryness
  • Complex dosing schedules
  • Poor adherence

In some cases, pressure appears controlled, but damage continues.

More medication does not always mean better protection.


What Is Maximal Medical Therapy?

Maximal medical therapy refers to using the maximum safe combination of eye drops before considering laser or surgery.

But “maximum” is not always “optimal.”

It can result in:

  • Ocular surface damage
  • Poor compliance
  • Fluctuating eye pressure
  • Reduced quality of life

In many cases, laser or surgery may be safer than adding more drops. Glaucoma care is not reactive, it is risk-governed.


Fixed-Dose Combination Drops: A Smarter Approach

Fixed-dose combinations combine two medications in one bottle.

They help by:

  • Reducing the number of drops
  • Simplifying treatment
  • Improving adherence
  • Lowering preservative exposure

Often, simpler regimens protect vision better than complex ones.


What Is Preservative Load?

Many glaucoma drops contain preservatives. Using multiple medications increases cumulative preservative exposure, which can damage the eye surface.

This may cause:

Reducing drops, or using preservative-free options, can significantly improve comfort and safety.


Why More Glaucoma Drops is Not Better Glaucoma Care

SituationWhat Patients Often ThinkWhat Is Actually HappeningWhat Better Care Looks Like
Pressure still high“Add another drop”Target pressure may be wrong or disease is progressing despite treatmentReassess diagnosis, stage, and target pressure
Multiple drops prescribed“More medicines = stronger treatment”Overmedication increases side effects without improving outcomesRationalise drops, simplify regimen
Eyes becoming red / irritated“Drops are working but causing minor issues”Ocular surface damage from preservatives affecting adherenceSwitch to preservative-free or reduce drop burden
Vision feels worse despite “good reports”“Tests are normal, so everything is fine”Functional loss or fluctuation not captured in routine examsCorrelate symptoms with OCT + visual fields
Frequent drop changes“Doctor is trying different combinations”Lack of structured long-term planEstablish stable, personalised treatment pathway
Difficulty remembering drops“I just need to be more careful”Complex regimens reduce compliance and effectivenessSimplify treatment or consider laser (SLT)
Long-term progression“Glaucoma just gets worse over time”Inadequate monitoring or delayed escalationTimely escalation: laser or surgery when needed

Glaucoma Care Is Not Just About Pressure

Effective glaucoma management looks beyond numbers:

  • Optic nerve structure
  • OCT trends over time
  • Visual field progression
  •  Target IOP
  • Medication tolerance
  •  Lifestyle and adherence

More treatment is not always better treatment. The right treatment, at the right time, matters more.

Clinical Reality (What’s Not Always Obvious)

  1. More drops does not mean better control
    Adding medications can feel like escalation, but without reassessing the disease, it may not improve long-term outcomes.
  2. A “good” pressure reading can be misleading
    One normal reading does not guarantee stability—glaucoma damage can continue silently between visits.
  3. Treatment can become habit instead of strategy
    Over time, care may drift into simply adding or switching drops rather than redefining targets and plans.
  4. Side effects quietly affect outcomes
    Multiple preserved drops can irritate the ocular surface, making patients less consistent with treatment.
  5. Stable reports don’t always mean stable disease
    Individual tests may look fine, but progression often appears only when data is tracked over time.
  6. Complex regimens reduce adherence
    The more complicated the schedule, the harder it becomes to follow consistently—reducing real-world effectiveness.
  7. Escalation is often delayed
    Laser or surgery may be postponed because “something is being done,” even if it’s no longer enough.
  8. Follow-up gaps change the disease trajectory
    Longer intervals without structured review can allow subtle progression to go unnoticed.
  9. Targets are not always redefined
    As glaucoma advances, the required pressure often needs to be lower—but this isn’t always updated.
  10. Activity is mistaken for effectiveness
    More visits, more drops, more changes—these can create the illusion of control without actually protecting vision.

When Laser or Surgery May Be Safer

Laser or surgery may be recommended if:

  • Target pressure is not achieved
  • Drops cause significant side effects
  • Adherence is difficult
  • Disease continues to progress
  • Risk of vision loss is high

These decisions are about long-term safety, not treatment failure.


Signs Your Glaucoma Treatment Needs Review

Consider a second opinion if you notice:

  • Increasing number of medications
  • Persistent redness or irritation
  • Confusing or difficult schedules
  • “Normal” pressure but worsening tests
  • High cost or poor affordability
  • Reduced quality of life

Treatment should feel sustainable and tolerable.


Why an Independent Glaucoma Review Helps

Glaucoma decisions are complex and long-term.

structured second opinion can help:

  • Reconfirm diagnosis
  • Reassess target IOP
  • Simplify medications
  • Identify better options
  • Avoid overtreatment

Especially important if you are on 3 or more eye drops.


The Real Goal of Glaucoma Care

Not perfect pressure numbers. Not maximum medications.

The goal is:

  • Right treatment
  • Right timing
  • Minimal burden
  • Long-term stability

More eye drops do not always mean better care.


FAQs

1. Do more glaucoma eye drops mean better treatment?

No. More drops do not necessarily improve outcomes. Treatment must be tailored to your risk profile and disease progression, not just escalated.


2. How many glaucoma drops are too many?

There is no fixed number, but if you are on 3 or more medications, your treatment strategy should be reviewed for effectiveness, tolerance, and alternatives.


3. Why do glaucoma drops stop working?

Glaucoma may progress despite treatment, or medications may become less effective over time. Poor adherence and incorrect sequencing also play a role.


4. What are the side effects of multiple glaucoma drops?

Common side effects include redness, burning, dryness, allergy, blurred vision, and poor tolerance, especially with long-term use.


5. What is target eye pressure in glaucoma?

Target IOP is the pressure level considered safe for your optic nerve. It varies based on damage, age, and progression risk.


6. Are laser or surgery better than eye drops?

In some cases, yes. If drops are not effective or tolerated, laser or surgery may offer safer long-term control.


7. What are fixed combination glaucoma drops?

These combine two medications in one bottle, helping reduce drop burden, improve compliance, and lower preservative exposure.


8. When should I get a second opinion for glaucoma?

If you are on multiple drops, still progressing, or experiencing side effects, a second opinion can help optimise your treatment plan.

 Book a glaucoma care review

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Talks, Media & Appearances

Dr Shibal Bhartiya is an invited speaker at national and international ophthalmology platforms, with appearances spanning the Glaucoma Society of India, the All India Ophthalmological Society, academic CME programmes, and public media. Below are some selected videos, talks, media and appearances.

Her work sits at the intersection of clinical glaucoma care, research, and systems-level thinking in early detection, risk, and continuity of care.

Featured Appearances

World Glaucoma Week Masterclass — Glaucoma Society of India (2026)
https://www.youtube.com/watch?v=gtBhui_Q2X4

Glauco-Talks Journal Club — Glaucoma Society of India (2025)
https://www.youtube.com/watch?v=nk6h4C4SSr0

Conference & CME Appearances

All India Ophthalmological Society (AIOS)

Philosophy of Medical Management of Glaucoma (2022)
https://www.youtube.com/watch?v=89-1XbGKPJg

AIOC 2021 Presentation
https://www.youtube.com/watch?v=Deo5_Ab0PYw

AI and Big Data: The Future of Medicine (2020)
https://www.youtube.com/watch?v=9EuzPfTOLi8

Lasers for Cyclodestruction (2020)
https://www.youtube.com/watch?v=u81Fncav998

Sankara Eye Foundation & CME
https://www.youtube.com/watch?v=IhCdSIbbMwE

International Platform — Ellex (Lumibird Medical)
https://www.youtube.com/watch?v=ZPuzM19KiRY

Media Appearances

Glaucoma Awareness — Doc Speak Series (2024)
https://www.youtube.com/watch?v=-6c6LYOnAKk

Avoiding Common Eye Care Mistakes (2023)
https://www.youtube.com/watch?v=Oka6qqRev-U

World Sight Day — TV9 Bharatvarsh (2022)
https://www.youtube.com/watch?v=tB4KX84C7tQ

Diabetes and Eye Health (2022)
https://www.youtube.com/watch?v=yn61NFHCJ6M

Brut India –Covid “Do You Live Alone? Keep These Things In Mind” (2020)

https://www.brut.media/in/videos/health/health-medicine/do-you-live-alone-keep-these-things-in-mind

Glaucoma Awareness — OnlyMyHealth (2019)
https://www.youtube.com/watch?v=7RIAH72vm5k

Digital Eye Strain — Work from Home (2021)
https://www.youtube.com/watch?v=ydQVgeahlM4

Author Appearances — Bena’s Summer

Author Speaks — HarperCollins
https://www.youtube.com/watch?v=atbxrc6VZ7Q

Author Webinar — Collins Learning
https://www.youtube.com/watch?v=lZDmdtK099c

The New Indian Express – launch of “Bena’s Summer”

Financial Express – children’s bookshelf feature for “Bena’s Summer”

Vision Unlimited & Social Impact

Hindustan Times featured Dr Shibal Bhartiya and Vision Unlimited’s work supporting children through after-school learning, nutrition, health, and community care in Gurugram.
Read the feature here; Published May 2026

A conversation on resilience, social impact, and building Vision Unlimited.

Times of India – women fearing second lockdown due to domestic violence

The Better India – Covid preparedness for people living alone

The Indian Express – balancing motherhood and medicine during Covid

Restaurant India – Vision Unlimited helping migrant workers during lockdown

https://timesofindia.indiatimes.com/city/gurgaon/doctor-her-trust-take-food-soap-to-the-needy/amp_articleshow/75113307.cms

Medical / Thought Leadership

Dr Shibal Bhartiya explains how early diagnosis, digital screening, and treatment advances are changing glaucoma care in India. Glaucoma in India: Early Diagnosis, Modern Care Transform Landscape

अब ज्यादा दूर तक नहीं देख पा रहे शहरी बच्चे, Nazariya Hindi News – Hindustan https://share.google/adWsR6I8m1cwopHI3

The New Indian Express – AI in eye surgery and future of ophthalmology

https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/world-retina-day-doctor-approved-tips-for-lifelong-retinal-health/amp_articleshow/124183692.cms

https://www.financialexpress.com/business/healthcare-blood-shot-eyes-even-after-recovering-from-eye-flu-heres-what-it-means-3213694/lite

https://www.healthshots.com/preventive-care/self-care/8-ways-to-manage-cataracts-at-home/amp

https://www.ndtv.com/health/world-sight-day-2020-blink-more-often-to-prevent-computer-vision-syndrome-know-more-expert-tips-2306974

https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/5-habits-that-are-making-your-eyes-weak/amp_articleshow/112758306.cms

https://timesofindia.indiatimes.com/life-style/health-fitness/diet/is-it-healthy-to-eat-rice-more-than-once-in-a-day/amp_articleshow/113688331.cms

https://foxinterviewer.com/healthcare/top-10-

FAQs

Who is a glaucoma specialist in Gurgaon?
A glaucoma specialist is an ophthalmologist trained in diagnosing and managing glaucoma, focusing on early detection, pressure control, and long-term vision preservation.


Where can I find a glaucoma expert in India?
Glaucoma experts are available in major cities like Gurgaon, Delhi, and Mumbai, with specialised clinics offering advanced diagnostics and second opinions.


What does a glaucoma specialist do?
A glaucoma specialist evaluates optic nerve health, visual fields, and eye pressure to detect disease early and prevent irreversible vision loss.


When should I see a glaucoma specialist?
You should consult a glaucoma specialist if you have high eye pressure, family history, vision changes, or are above 40 years of age.


Why are glaucoma talks and awareness important?
Glaucoma often has no early symptoms. Public awareness and expert talks help promote early detection and prevent blindness.

Credentials & Professional Profile

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience.

She is Editor-in-Chief of Clinical and Experimental Vision and Eye Research (CLEVER) and Executive Editor of the Journal of Current Glaucoma Practice (JCGP).

Her academic work includes over 200 publications, 90+ PubMed-indexed papers, and 28 edited textbooks.

Credentials And Professional Profile

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. Her clinical philosophy emphasises early detection, risk-based care, ethical decision-making, and independent second opinions.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Explore More

PubMed
https://pubmed.ncbi.nlm.nih.gov/?term=shibal+bhartiya

Google Scholar
https://scholar.google.com/citations?user=tzGqA1EAAAAJ

ORCID
https://orcid.org/0000-0002-1947-5474

Glaucoma Care in Gurgaon

Dr Shibal Bhartiya provides glaucoma care in Gurgaon, focusing on early detection, risk stratification, and long-term management of glaucoma to prevent irreversible vision loss. Care typically includes detailed optic nerve evaluation, OCT and visual fields, and personalised treatment plans tailored to disease stage and progression risk.

Early detection. Risk-based care. Long-term vision protection. Glaucoma often develops silently, but the risk can be identified early with the right tests and careful interpretation, before vision loss becomes irreversible. Dr Shibal Bhartiya, fellowship-trained glaucoma specialist in Gurgaon, brings together evidence-based insights on screening, risk stratification, and long-term care to help protect vision over time.

Glaucoma is a silent, progressive disease. Vision loss often occurs gradually and cannot be reversed. The goal of care is not just lowering eye pressure, but protecting the optic nerve safely over time.

If you are looking for a glaucoma specialist in Gurgaon, treatment decisions should be based on risk, progression, and long-term safety, not just the number of medications.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


🧠 A Different Approach to Glaucoma Care

Glaucoma is often managed reactively, pressure rises, more drops are added. But glaucoma is a long-arc disease.

Effective care focuses on:

This is not about doing more. It is about doing what is right, at the right time.


🔎 Start Here: Understanding Your Glaucoma

If you are trying to understand your diagnosis or treatment, these guides will help:


⚠️ When Should You Be Concerned?

You should consider evaluation if you have:

  • Family history of glaucoma
  • Increasing number of eye drops
  • Redness, irritation, or intolerance to medications
  • “Normal” eye pressure but worsening reports
  • Difficulty understanding your treatment plan

Glaucoma often progresses silently. Waiting for symptoms can delay care.

If this sounds familiar, it may be time to consider a glaucoma second opinion:
https://drshibalbhartiya.com/glaucoma-second-opinion-gurgaon/


🧪 How Glaucoma Is Evaluated

Accurate glaucoma care requires more than a pressure check.

Assessment includes:

Understanding glaucoma progression through OCT and visual field analysis is key to making safe treatment decisions.


💊 Treatment Is Not Just About Eye Drops

Treatment options may include:

Adding more medications is not always the safest approach.
In many cases, treatment strategy matters more than the number of drops used:
https://drshibalbhartiya.com/more-glaucoma-eye-drops-not-better-care/

Target IOP

Managing side effects of glaucoma drops


🔁 Long-Term Care Matters

Glaucoma requires:

  • Regular follow-up
  • Consistent monitoring
  • Adjustment based on progression

The goal is:

  • Stable vision
  • Minimal side effects
  • Sustainable treatment

👁️ Not Sure Where You Stand?

If:

  • you are on multiple eye drops
  • your reports are difficult to interpret
  • or your condition seems to be progressing

A structured evaluation can help simplify your treatment.

👉 Request a glaucoma second opinion:
https://drshibalbhartiya.com/glaucoma-second-opinion-gurgaon/

Clinical Reality (What’s not always obvious)

  • Good glaucoma care is not a one-time consultation—it’s longitudinal monitoring of glaucoma over years.
  • A “normal” eye pressure does not guarantee safety—progression can occur despite seemingly controlled numbers.
  • Technology (OCT, visual fields) supports care, but clinical judgement and pattern recognition over time are what prevent vision loss.
  • Over-treatment (too many drops) and under-treatment (delayed escalation) are both risks—balance is key.
  • The quality of follow-up and consistency of care often matter more than any single test or visit.

What you Must Remember

AspectWhat It Means for You
Core goalPreserve vision long-term by slowing disease progression
Key evaluationsOptic nerve exam, OCT, visual fields, eye pressure
Treatment optionsEye drops, laser (SLT), surgery if needed
Follow-up importanceRegular monitoring detects early progression
PersonalisationCare tailored to risk, lifestyle, and response
When to seek specialist careUncertain diagnosis, progression, second opinion
Role of technologySupports early detection and tracking
Systemic factorsSleep, blood pressure, health influence outcomes
Patient roleAdherence to treatment and follow-up is critical
Big pictureGlaucoma care is ongoing risk management, not a one-time fix

FAQs About Glaucoma Care in Gurgaon

When should I see a glaucoma specialist in Gurgaon?

You should see a glaucoma specialist if you have a family history of glaucoma, are on an increasing number of eye drops, experience redness or irritation from your medications, have been told your eye pressure is normal but your reports are worsening, or find your current treatment plan difficult to understand. Glaucoma often progresses silently. Waiting for symptoms can delay care and lead to irreversible vision loss.


What tests are done in a glaucoma evaluation?

A comprehensive glaucoma evaluation includes optic nerve examination, OCT imaging of the optic nerve and retinal nerve fibre layer, visual field testing, corneal thickness measurement, and risk profiling over time. A pressure check alone is not sufficient to evaluate or manage glaucoma safely. Each of these tests contributes a different piece of information about disease risk and progression.


What is a glaucoma second opinion and when is it needed?

A glaucoma second opinion is a structured, independent review of your diagnosis and treatment plan. It is useful when you are on multiple eye drops, when your condition seems to be progressing despite treatment, when reports are difficult to interpret, or when your treatment plan feels unclear. Dr Shibal Bhartiya offers dedicated glaucoma second opinion consultations in Gurgaon, with a focus on simplifying decisions and protecting vision long-term.


Is adding more eye drops always the right treatment for glaucoma?

No. Adding more medications is not always the safest or most effective approach. Glaucoma treatment should be based on risk, rate of progression, side effect burden, and long-term safety. In many cases, treatment strategy matters more than the number of drops prescribed. Laser procedures or surgical options may be more appropriate than escalating medications, depending on the individual case.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Related Reading

Get an Online Glaucoma Consult

Why Do I Need a Visual Field Test?

Understanding Your OCT Report in Glaucoma

Visual Field and OCT: Structure & Function Correlation

Gonioscopy

Glaucoma Diagnosis in Gurgaon

Glaucoma Progression: What It Means and How to Slow It

Glaucoma treatment in Gurgaon

All About Glaucoma Medication

Glaucoma Lasers: SLT & LPI

Glaucoma surgery in Gurgaon

MIGS in Gurgaon

Get a Glaucoma Second Opinion in Gurgaon